Drug:
Reaction: GASTROINTESTINAL DISORDER
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26513567 |
US |
2 | |
Gastrointestinal disorder, |
||||
| 202 | 26513619 |
US |
1 | |
Gastrointestinal disorder, Inappropriate schedule of product administration, |
||||
| 203 | 26513830 |
US |
7 | 2 |
Pleural effusion, Gastrointestinal disorder, |
||||
PIOGLITAZONE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ROSUVASTATIN, |
||||
| 204 | 26514205 |
IN |
||
Drug intolerance, Gastrointestinal disorder, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 205 | 26514406 |
EU |
32 | 2 |
Hepatic hydrothorax, Skin hypopigmentation, Abdominal distension, Ear discomfort, Abdominal rigidity, Pain in extremity, Dyspnoea at rest, Pain in jaw, Dyspnoea, Dyspepsia, Headache, Insomnia, Hospitalisation, Gastrointestinal disorder, Cough, Dyspnoea exertional, Weight increased, Pulmonary hypertension, Oxygen saturation decreased, Weight decreased, Vomiting, Fatigue, Diaphragmatic injury, Back pain, Gastrointestinal pain, Myalgia, Nausea, Cold sweat, Hypoglycaemia, Increased appetite, Palpitations, Decreased appetite, Restlessness, Epistaxis, Muscular weakness, Nasopharyngitis, Flushing, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, FUROSEMIDE, TADALAFIL, AMBRISENTAN, |
||||
| 206 | 26514834 |
US |
40 | 1 |
Gastrointestinal disorder, |
||||
RISANKIZUMAB-RZAA, |
||||
| 207 | 26514899 |
CA |
40 | 2 |
Hepatitis, Wound infection, Headache, Muscular weakness, Back injury, Hypoaesthesia, Gastrointestinal disorder, Weight increased, Folliculitis, Condition aggravated, Pneumonia, Coeliac disease, Liver function test increased, Off label use, Musculoskeletal stiffness, Gait inability, Product label confusion, Injury, Intentional product use issue, Wheezing, Mobility decreased, Insomnia, Adverse reaction, Pain in extremity, Abdominal distension, Fall, Bursitis, Grip strength decreased, Nail disorder, Finger deformity, Gastrooesophageal reflux disease, Neck pain, Dyspepsia, Malaise, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, CANDESARTAN CILEXETIL, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 208 | 26515085 |
CA |
43 | 2 |
Alopecia, Contusion, Folliculitis, Dyspnoea, Gastrointestinal disorder, Ill-defined disorder, Glossodynia, Headache, Hypertension, Impaired healing, |
||||
SECUKINUMAB, RISEDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREGABALIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CANDESARTAN, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB-ADAZ, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 209 | 26515676 |
US |
38 | 2 |
Renal disorder, Gastrointestinal disorder, |
||||
VOCLOSPORIN, |
||||
| 210 | 26515774 |
CA |
1 | |
Gastrointestinal disorder, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 211 | 26515871 |
US |
1 | |
Chemotherapy, Constipation, Dyspepsia, Gastrointestinal disorder, |
||||
PANCRELIPASE, |
||||
| 212 | 26516058 |
EU |
37 | 2 |
Skin cancer, Depressed mood, Pruritus, Nephrolithiasis, Gallbladder disorder, Taste disorder, Appetite disorder, Abdominal distension, Abdominal pain, Gastrointestinal disorder, Renal colic, |
||||
SEMAGLUTIDE, |
||||
| 213 | 26516320 |
BR |
87 | 2 |
COVID-19, Gastrointestinal disorder, |
||||
IXAZOMIB, |
||||
| 214 | 26516579 |
US |
73 | 1 |
Gastrointestinal disorder, Blood pressure decreased, Dizziness, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 215 | 26519227 |
66 | 2 | |
Autoscopy, Gastrointestinal disorder, Akathisia, Fear, Dyspnoea, Confusional state, Suicidal ideation, Syncope, Insomnia, Hyperthyroidism, Pancreatitis, COVID-19, Withdrawal syndrome, Congenital pancreatic anomaly, Cognitive disorder, Burning sensation, |
||||
CLONAZEPAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, LISDEXAMFETAMINE DIMESYLATE, PROPRANOLOL HYDROCHLORIDE, MAGNESIUM, ERGOCALCIFEROL, PHYTONADIONE, ACTAEA SPICATA, AMMONIUM BENZOICUM, ARNICA MONTANA, BELLIS PERENNIS, BERBERIS VULGARIS, BRYONIA, CHELIDONIUM MAJUS, CHININUM SULPHURICUM, DULCAMARA LIGNOSA WHOLE, ECHINACEA PURPUREA, FORMICA RUFA, FRAXINUS EXCELSIOR LEAF, LACTICUM ACIDUM, LEDUM PALUSTRE, PULSATILLA VULGARIS, RHODODENDRON CHRYSANTHUM, RHUS TOXICODENDRON, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SYMPHYTUM OFFICINALE, URICUM ACIDUM, ARNICA MONTANA, ASCORBICUM ACIDUM, BOS TAURUS LYMPH VESSEL, INTERVERTEBRAL FIBROCARTILAGE, BOS TAURUS MESENCHYME, CALCAREA PHOSPHORICA, CARTILAGO SUIS, FORMICUM ACIDUM, LAPIS ALBUS, PINUS MONTANA LEAFY TWIG, RHAMNUS CALIFORNICA, RHUS TOXICODENDRON, RUTA GRAVEOLENS, SILICEA, SUS SCROFA JOINT ENVELOPE, SUS SCROFA LIGAMENT, SUS SCROFA MENISCUS, SUS SCROFA PARATHYROID GLAND, SUS SCROFA VEIN, SYMPHYTUM OFFICINALE, ABIES ALBA LEAFY TWIG, CALCAREA ACETICA, CALCAREA ARSENICICA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA HYPOPHOSPHOROSA, CALCAREA IODATA, CALCAREA MURIATICA, CALCAREA OXALICA, CALCAREA PHOSPHORICA, CALCAREA PICRATA, CALCAREA SULPHURICA, CALCULUS BOVIS, CALENDULA OFFICINALIS, CHOLESTERINUM, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, LAPIS ALBUS, SILICEA, SULPHUR IODATUM, SUS SCROFA PARATHYROID GLAND, SYMPHYTUM OFFICINALE, URTICA URENS, VITAMIN D, APIS MELLIFICA, AURUM MURIATICUM NATRONATUM, BERBERIS VULGARIS, BOS TAURUS PITUITARUM POSTERIUM, CALCAREA FLUORICA, CALCAREA IODATA, CONIUM MACULATUM, FRAXINUS AMERICANA, HYDRASTIS CANADENSIS, HYDROFLUORICUM ACIDUM, LAPIS ALBUS, PANCREATINUM, SARCOLACTICUM ACIDUM, SEPIA, SULPHUR IODATUM, THIOSINAMINUM, THUJA OCCIDENTALIS, THYROIDINUM, QUERCETIN, QUERCETIN,, |
||||
| 216 | 26519580 |
76 | 2 | |
Neuropathy peripheral, Paraesthesia, Vision blurred, Pain, Electric shock sensation, Speech disorder, Nonspecific reaction, Hypoaesthesia, Therapy interrupted, Urinary tract infection, Tinnitus, Head discomfort, Gastrointestinal disorder, Blood pressure increased, |
||||
MOMELOTINIB, |
||||
| 217 | 26507696 |
US |
2 | |
Pain, Gastrointestinal disorder, Abdominal pain upper, |
||||
PANCRELIPASE, |
||||
| 218 | 26508443 |
IN |
48 | 1 |
Irritability, Asthenia, Hypoaesthesia, Gastrointestinal disorder, Dyspnoea, Prescription drug used without a prescription, Drug level above therapeutic, Confusional state, Generalised oedema, Withdrawal syndrome, Intentional product misuse, Drug dependence, Drug abuse, Wheezing, Headache, Sleep disorder, Depressed mood, Weight increased, Paraesthesia, |
||||
PREGABALIN, PREGABALIN, |
||||
| 219 | 26508494 |
CN |
38 | 1 |
Gastrointestinal disorder, Nausea, Vomiting, Abdominal pain, Abdominal distension, |
||||
| 220 | 26509581 |
EU |
46 | 2 |
Gastrointestinal disorder, Skin toxicity, Adenocarcinoma of colon, Alopecia, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Lymphocyte percentage decreased, Red cell distribution width increased, |
||||
PANITUMUMAB, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, CAPECITABINE, |
||||
| 221 | 26509599 |
EU |
2 | |
Gastrointestinal toxicity, Gastrointestinal disorder, Asthenia, |
||||
DURVALUMAB, DURVALUMAB, OLAPARIB, OLAPARIB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 222 | 26509782 |
TH |
||
Fatigue, Decreased appetite, Oropharyngeal pain, Hypophagia, Diarrhoea, Urine output decreased, Neurogenic bladder, Abdominal pain, Pain, Ill-defined disorder, Gastrointestinal disorder, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 223 | 26509975 |
|||
Gastrointestinal disorder, Psoriasis, Brain fog, Blood cholesterol, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, CELECOXIB, TAMSULOSIN HYDROCHLORIDE, ERGOCALCIFEROL, RIVAROXABAN, |
||||
| 224 | 26511472 |
US |
7 | 1 |
Gastrointestinal disorder, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, |
||||
| 225 | 26511497 |
US |
63 | 2 |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 226 | 26511791 |
CA |
40 | 2 |
Abdominal distension, Arthralgia, Arthropathy, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Contusion, Depression, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Wheezing, Wound, Wound infection, Abdominal pain upper, Alopecia, Asthenia, Diarrhoea, Lower respiratory tract infection, Hepatitis, Drug-induced liver injury, Hypotension, Malaise, Nausea, Pneumonia, Rash, Vomiting, Abdominal discomfort, |
||||
AZATHIOPRINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LAMOTRIGINE, LAMOTRIGINE, MEPOLIZUMAB, |
||||
| 227 | 26511852 |
US |
2 | |
Fatigue, Headache, Gastrointestinal disorder, Muscle spasms, Back pain, |
||||
DANICOPAN, ECULIZUMAB, |
||||
| 228 | 26512097 |
US |
53 | 2 |
Bell^s palsy, Fatigue, Asthenia, Decreased appetite, Gastrointestinal disorder, Papilloma viral infection, Disturbance in attention, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 229 | 26512162 |
US |
2 | |
Disability, Gastrointestinal disorder, |
||||
LINACLOTIDE, |
||||
| 230 | 26514338 |
79 | 2 | |
Dizziness, Headache, Malaise, Sinusitis, Influenza, Gastrointestinal disorder, Gastrooesophageal reflux disease, Thinking abnormal, Skin disorder, Pain, |
||||
MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM POLYCARBOPHIL, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, DIPHENHYDRAMINE HYDROCHLORIDE, AMLODIPINE, EVOLOCUMAB, GABAPENTIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 231 | 26515274 |
1 | ||
Gastrointestinal disorder, |
||||
PANTOPRAZOLE SODIUM, MONTELUKAST, |
||||
| 232 | 26503449 |
EU |
18 | |
Crohn^s disease, Diarrhoea haemorrhagic, Attention deficit hyperactivity disorder, Gastrointestinal disorder, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 233 | 26503884 |
US |
61 | |
Viral infection, Pneumonia, Gastrointestinal disorder, Malaise, Eructation, Diarrhoea, Abdominal pain, Lethargy, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 234 | 26504085 |
|||
Eating disorder, Gastrointestinal disorder, Malaise, |
||||
BIMEKIZUMAB, |
||||
| 235 | 26504914 |
EU |
1 | |
Syncope, Loss of consciousness, Gastrointestinal disorder, Hypotension, Pallor, |
||||
OCRELIZUMAB, |
||||
| 236 | 26505000 |
US |
2 | |
Death, Lung carcinoma cell type unspecified stage IV, Hepatotoxicity, Diarrhoea, Decreased appetite, Gastrointestinal disorder, |
||||
SOTORASIB, |
||||
| 237 | 26505051 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Product use issue, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
RITUXIMAB, RITUXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ROSUVASTATIN, ROSUVASTATIN CALCIUM, USTEKINUMAB, LEVOTHYROXINE SODIUM, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 238 | 26505120 |
US |
2 | |
Gastrointestinal disorder, |
||||
TISOTUMAB VEDOTIN, |
||||
| 239 | 26505366 |
US |
||
Rash, Gastrointestinal disorder, |
||||
ACALABRUTINIB, |
||||
| 240 | 26505452 |
US |
1 | |
Gastrointestinal disorder, Acne, Hypersomnia, Fatigue, Blood glucose abnormal, Headache, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, |
||||
| 241 | 26505487 |
EU |
21 | 2 |
Febrile neutropenia, Gastrointestinal disorder, Inflammation, Stomatitis, Gastrointestinal inflammation, Condition aggravated, Herpes simplex, Flatulence, |
||||
FILGRASTIM, BRENTUXIMAB VEDOTIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DACARBAZINE, MORPHINE, |
||||
| 242 | 26505639 |
US |
67 | 1 |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, |
||||
| 243 | 26505671 |
US |
55 | 2 |
Gastrointestinal disorder, Tryptase, |
||||
AVAPRITINIB, CLONAZEPAM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PROGESTERONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROCHLORPERAZINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, CARIPRAZINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VITAMIN C, MAGNESIUM OXIDE, PHENTERMINE HYDROCHLORIDE, |
||||
| 244 | 26505911 |
US |
2 | |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 245 | 26506010 |
US |
2 | |
Gastrointestinal disorder, |
||||
| 246 | 26506796 |
|||
Gastrointestinal disorder, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 247 | 26507072 |
EU |
18 | |
Crohn^s disease, Diarrhoea haemorrhagic, Attention deficit hyperactivity disorder, Gastrointestinal disorder, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 248 | 26507374 |
US |
60 | 2 |
Gastrointestinal disorder, Hunger, Decreased activity, Flatulence, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 249 | 26507525 |
GB |
||
Acetabulum fracture, Acute sinusitis, Tonsillitis, Drug ineffective, Nervous system disorder, Gastrointestinal disorder, Respiratory disorder, Mediastinal disorder, Spinal disorder, Oropharyngeal pain, Infection, Injection site reaction, Nasopharyngitis, Pyrexia, Hypersensitivity, Headache, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 250 | 26509791 |
33 | 1 | |
Product dispensing error, Wrong product administered, Withdrawal syndrome, Gastrointestinal disorder, Abdominal pain, Constipation, Vertigo, Coordination abnormal, Contusion, Contusion, Fall, Ligament sprain, Ligament sprain, Anxiety, Irritability, Tachycardia, |
||||
MELOXICAM, SERTRALINE HYDROCHLORIDE, |
||||
| 251 | 26498142 |
US |
2 | |
Gastrointestinal disorder, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 252 | 26498463 |
US |
2 | |
Gastrointestinal disorder, |
||||
RISEDRONATE SODIUM, |
||||
| 253 | 26498636 |
EU |
||
Gastrointestinal disorder, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 254 | 26498900 |
US |
2 | |
Seizure, Nausea, Gastrointestinal disorder, Drug intolerance, Vomiting, Diarrhoea, Influenza, Gait disturbance, Electroencephalogram abnormal, Underdose, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, OXCARBAZEPINE, |
||||
| 255 | 26498906 |
JP |
||
Gastrointestinal disorder, |
||||
DENOSUMAB, |
||||
| 256 | 26499368 |
US |
64 | 2 |
Neuropathy peripheral, Migraine, Nasal operation, Thyroid disorder, Loss of personal independence in daily activities, Near death experience, Gastrointestinal disorder, |
||||
FREMANEZUMAB-VFRM, |
||||
| 257 | 26499590 |
US |
1 | |
Gastrointestinal disorder, |
||||
APREMILAST, |
||||
| 258 | 26499673 |
US |
||
Depression, Dry skin, Gastrointestinal disorder, Nausea, |
||||
ISOTRETINOIN, |
||||
| 259 | 26499813 |
CA |
47 | 2 |
Abdominal discomfort, Abdominal pain upper, Arthralgia, Cardiac failure, Cardiac failure congestive, Contraindicated product administered, Cough, Diarrhoea, Drug hypersensitivity, Drug intolerance, Dyspnoea, Gastrointestinal disorder, Headache, Hepatic enzyme increased, Hepatic steatosis, Hypersensitivity, Hypertension, Liver disorder, Loss of employment, Malaise, Nausea, Off label use, Pain, Product use issue, Rash, Therapeutic product effect decreased, |
||||
RITUXIMAB, RITUXIMAB, LEUCOVORIN CALCIUM, CIPROFLOXACIN HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, GOLD, ADALIMUMAB, ADALIMUMAB, LEUCOVORIN CALCIUM, PERINDOPRIL ERBUMINE, PREDNISONE, PREDNISONE, PREDNISONE, RANITIDINE, RANITIDINE HYDROCHLORIDE, PATIROMER, |
||||
| 260 | 26500290 |
CA |
79 | 2 |
Sepsis, Gallbladder rupture, Asthenia, Decreased appetite, Illness, Urinary tract infection, Hypotension, Frequent bowel movements, Faeces discoloured, Drug level decreased, Gastrointestinal disorder, Cough, Respiratory tract congestion, Vomiting, Headache, Dizziness, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 261 | 26500680 |
BR |
51 | 2 |
Gastrointestinal disorder, Constipation, Abdominal discomfort, Throat irritation, Dysgeusia, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 262 | 26500896 |
84 | ||
Stomatitis, Insomnia, Nausea, Gastrointestinal disorder, Fatigue, Off label use, |
||||
| 263 | 26501065 |
EU |
36 | 1 |
Fungal oesophagitis, Gastroenteritis astroviral, Nausea, Vomiting, Hypokalaemia, Diarrhoea, Gastrointestinal disorder, Off label use, Intentional product misuse, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, THIOTEPA, THIOTEPA, THIOTEPA, THIOTEPA, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SIROLIMUS, SIROLIMUS, SIROLIMUS, SIROLIMUS, |
||||
| 264 | 26501163 |
US |
62 | 1 |
Gastrointestinal disorder, Multiple organ dysfunction syndrome, Hypovolaemia, Gastritis, Anaemia, Strongyloidiasis, Duodenitis, Drug ineffective, Hypoxia, Abdominal pain, Septic shock, Diarrhoea, Thrombocytopenia, Weight decreased, Nausea, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, BASILIXIMAB, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, GENTAMICIN, GENTAMICIN SULFATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AZATHIOPRINE, MEROPENEM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, |
||||
| 265 | 26501427 |
US |
1 | |
Joint swelling, Pain, Gastrointestinal disorder, |
||||
| 266 | 26501574 |
US |
||
Biliary colic, Drug intolerance, Gastrointestinal disorder, Diarrhoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, TREPROSTINIL, MAGNESIUM OXIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SILDENAFIL CITRATE, SILDENAFIL, MACITENTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SPIRONOLACTONE, CLONAZEPAM, OXYGEN, 0XYGEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMBRISENTAN, |
||||
| 267 | 26502076 |
CA |
2 | |
Anti-cyclic citrullinated peptide antibody positive, Abdominal discomfort, Alopecia, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Drug ineffective, Drug intolerance, Contraindicated product administered, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, PREDNISOLONE ACETATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXAMETHASONE SODIUM PHOSPHATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SULFASALAZINE, SULFASALAZINE, |
||||
| 268 | 26502132 |
US |
19 | |
Gastrointestinal disorder, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 269 | 26502170 |
EU |
2 | |
Disease progression, Asthenia, Gastrointestinal disorder, Disease progression, Diarrhoea, Nausea, Fatigue, |
||||
NINTEDANIB, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, RAMIPRIL, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, RANOLAZINE, PREDNISONE, RANOLAZINE, VORTIOXETINE, CALCIUM CARBONATE, ANTACID, |
||||
| 270 | 26502615 |
EU |
81 | 1 |
Renal failure, Gastrointestinal disorder, Abdominal pain, Constipation, Cardiac failure, |
||||
| 271 | 26497474 |
US |
6 | 2 |
Gastrointestinal disorder, |
||||
RISDIPLAM, |
||||
| 272 | 26497475 |
US |
2 | |
Gastrointestinal disorder, |
||||
DIMETHYL FUMARATE, |
||||
| 273 | 26497741 |
US |
74 | 2 |
Flatulence, Gastrointestinal disorder, Constipation, |
||||
DULAGLUTIDE, |
||||
| 274 | 26497128 |
EU |
80 | 1 |
Gastrointestinal disorder, Decreased appetite, Malaise, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, RIFAMPIN, |
||||
| 275 | 26497155 |
US |
59 | 1 |
Chest discomfort, Gastrointestinal disorder, |
||||
UPADACITINIB, |
||||
| 276 | 26497301 |
JP |
77 | 2 |
Gastrointestinal disorder, Insomnia, Insomnia, Cystitis, Otitis media, Nausea, Constipation, |
||||
NINTEDANIB, |
||||
| 277 | 26491956 |
US |
1 | |
Gastrointestinal inflammation, Crohn^s disease, Gastrointestinal disorder, |
||||
RISANKIZUMAB-RZAA, |
||||
| 278 | 26492016 |
US |
71 | 2 |
Haemorrhoids, Abdominal pain upper, Haematochezia, Blood iron decreased, Haematochezia, Inflammatory marker decreased, Injection site rash, Gastrointestinal disorder, Gastrointestinal disorder, |
||||
RISANKIZUMAB-RZAA, |
||||
| 279 | 26492116 |
US |
||
Gastrointestinal disorder, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 280 | 26492634 |
CA |
62 | 2 |
Hip surgery, Intestinal stenosis, Gastrointestinal disorder, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 281 | 26492691 |
US |
||
Gastrointestinal disorder, |
||||
APREMILAST, |
||||
| 282 | 26492731 |
EU |
75 | 2 |
Syncope, Hepatitis B, Hepatic cirrhosis, Upper limb fracture, Dizziness, Gastrointestinal disorder, |
||||
DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE, |
||||
| 283 | 26492986 |
48 | ||
Gastrointestinal disorder, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 284 | 26493018 |
US |
64 | 2 |
Sinus operation, Gastrointestinal disorder, Swelling, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 285 | 26493318 |
US |
||
Pancreatitis, Gastrointestinal disorder, Weight decreased, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 286 | 26493518 |
CA |
80 | 1 |
Activated partial thromboplastin time prolonged, Anaemia, Analgesic therapy, Antacid therapy, Anticoagulant therapy, Aspiration, Asthenia, Asthma, Bacterial infection, Benign prostatic hyperplasia, Blood calcium increased, Blood creatinine increased, Blood test abnormal, Breath sounds abnormal, Bronchopulmonary aspergillosis allergic, Cardiovascular disorder, Chronic obstructive pulmonary disease, Condition aggravated, Congenital hiatus hernia, Coronary artery disease, Diabetes mellitus, Drug hypersensitivity, Drug intolerance, Drug therapy, End stage renal disease, Fatigue, Full blood count abnormal, Gastrointestinal disorder, General physical health deterioration, Gout, Headache, Hypercholesterolaemia, Hyperlipidaemia, Hyperphosphataemia, Hypertension, Hyponatraemia, Hypophosphataemia, Liver disorder, Lower respiratory tract infection, Lung disorder, Malignant melanoma stage 0, Micturition urgency, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Neuralgia, Oedema peripheral, Pain, Pleuritic pain, Pulmonary embolism, Pyrexia, Respiratory symptom, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Stress, Swelling, Thrombosis, Transaminases increased, Transient ischaemic attack, Tremor, Troponin increased, Ulcer, Upper respiratory tract infection, Joint injury, Incorrect route of product administration, Intentional product misuse, Product dose omission issue, Product use in unapproved indication, Off label use, Drug ineffective, |
||||
GABAPENTIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, ALLANTOIN, MEDICINAL MASSAGE OIL, ALLANTOIN, MEDICINAL MASSAGE OIL, ALLOPURINOL, AMIODARONE HYDROCHLORIDE, AMLODIPINE BESYLATE, AMMONIUM CHLORIDE, DARBEPOETIN ALFA, BETAMETHASONE DIPROPIONATE, BIOTIN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISMUTH SUBNITRATE, BUDESONIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCIUM, CANDESARTAN, CEFTRIAXONE SODIUM, CITRIC ACID, HYDROCORTISONE, DEXLANSOPRAZOLE, DEXTROSE MONOHYDRATE, DEXTROSE, DOBUTAMINE HYDROCHLORIDE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, PSYLLIUM HUSK, FOLIC ACID, FOLIC ACID, DALTEPARIN SODIUM, IPRATROPIUM BROMIDE, NITROGLYCERIN, HEPARIN SODIUM, HORSE CHESTNUT, HYDROMORPHONE HYDROCHLORIDE, INSULIN ASPART, EFINACONAZOLE, EFINACONAZOLE, HYDROMORPHONE HYDROCHLORIDE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LANTHANUM CARBONATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, MAGNESIUM CARBONATE, MAGNESIUM OXIDE, MANNITOL, MELATONIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, MOMETASONE FUROATE, NICOTINAMIDE, NITROGLYCERIN, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, MEPOLIZUMAB, ONDANSETRON HYDROCHLORIDE, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, MANNITOL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, VITAMIN C, POTASSIUM BROMIDE, |
||||
| 287 | 26494113 |
US |
76 | 2 |
Memory impairment, Gastrointestinal disorder, Wrong technique in product usage process, Accidental exposure to product, Device issue, Injection site pain, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, LOSARTAN, MELOXICAM, |
||||
| 288 | 26494343 |
US |
49 | 2 |
Gastrointestinal disorder, |
||||
INCLISIRAN, VEDOLIZUMAB, |
||||
| 289 | 26494446 |
US |
68 | 2 |
Dyspepsia, Arthralgia, Adverse event, Gastrointestinal disorder, Product use in unapproved indication, Dry mouth, |
||||
CARBIDOPA AND LEVODOPA, |
||||
| 290 | 26494901 |
US |
30 | 2 |
Drug ineffective, Feeling drunk, Gait disturbance, Gastrointestinal disorder, Dizziness, Tremor, |
||||
ZURANOLONE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, |
||||
| 291 | 26494938 |
|||
Diarrhoea, Gastrointestinal disorder, |
||||
NINTEDANIB, |
||||
| 292 | 26495212 |
US |
75 | 2 |
Gastrointestinal disorder, |
||||
AVAPRITINIB, CETIRIZINE HCL, CETIRIZINE, TADALAFIL, CLOPIDOGREL BISULFATE, MONTELUKAST SODIUM, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, EZETIMIBE, FAMOTIDINE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TADALAFIL, FENOFIBRATE, ISOSORBIDE MONONITRATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, |
||||
| 293 | 26495400 |
US |
71 | 1 |
Food poisoning, Haematemesis, Nephrolithiasis, Abdominal pain upper, Nausea, Vomiting, Gastrointestinal disorder, Constipation, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 294 | 26495436 |
US |
6 | 2 |
Gastrointestinal disorder, Product use in unapproved indication, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 295 | 26495598 |
US |
||
Gastrointestinal disorder, Flatulence, Headache, Dizziness, |
||||
TREPROSTINIL, TREPROSTINIL, NINTEDANIB, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FISH OIL, TAMSULOSIN HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EMPAGLIFLOZIN, FINERENONE, FLUOXETINE HYDROCHLORIDE, INSULIN GLARGINE, ERGOCALCIFEROL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ALPRAZOLAM, SEMAGLUTIDE, ORAL SEMAGLUTIDE, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, CARVEDILOL, IRON, |
||||
| 296 | 26495614 |
CA |
44 | 2 |
Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LORAZEPAM, CAFFEINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, ERGOCALCIFEROL, TRIMETHOPRIM, |
||||
| 297 | 26495787 |
US |
51 | 2 |
Perioral dermatitis, Rash macular, Skin tightness, Sensitive skin, Cheilitis, Visual brightness, Photopsia, Headache, Gastrointestinal disorder, |
||||
TUCATINIB, |
||||
| 298 | 26496103 |
30 | 1 | |
Systemic scleroderma, Retinal vasculitis, Retinal vasculitis, Cachexia, Scleroderma renal crisis, Gastrointestinal disorder, Chronic kidney disease, Hypergammaglobulinaemia benign monoclonal, Skin hypertrophy, Drug intolerance, Hypertension, |
||||
TADALAFIL, TADALAFIL, METHOTREXATE SODIUM, METHOTREXATE SODIUM, RITUXIMAB, |
||||
| 299 | 26496451 |
US |
||
Dehydration, Gastrointestinal disorder, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 300 | 26496597 |
AU |
47 | 1 |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
